Beryllium sulfate tetrahydrate

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P272, P273, P280, P284, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P318, P319, P320, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

H401: Toxic to aquatic life [Hazardous to the aquatic environment, acute hazard]

P273, P391, and P501 (click each P-code to see the statement)

Chemical: Sulfuric acid, beryllium salt(1:1), tetrahydrate

Beryllium sulphate tetrahydrate: HSNO Approval: HSR006289 Approved with controls

The New Jersey Worker and Community Right to Know Act requires public and private employers to provide information about hazardous substances at their workplaces. (N.J.S.A. 34:5A-1 et. seq.)

SYMPTOMS: Symptoms of exposure to this compound may include lung disease with cough, chest pain, shortness of breath, weight loss, weakness and fatigue. It may cause eye and skin irritation, rash and ulcers. Implantation may lead to wart-like granulomas. It may cause irritation or burns to the mouth, esophagus and stomach. It may also cause irritation to the respiratory system and cyanosis. It may cause conjunctivitis, hyperemia of the conjunctiva, edema of the lids, burning sensation and photophobia. Other symptoms of exposure may include difficulty breathing, anorexia, malaise, pneumonitis, nasopharyngitis, tracheobronchitis, dyspnea, conjunctival inflammation and dermatitis. It may cause rhinitis, death, pulmonary fibrosis, corpulmonale, respiratory insufficiency, cardiac arrest, virus pneumonia and renal insufficiency.